The currently available survival models for patients with lung cancer and bone metastases were developed in the era of chemotherapy and do not accurately reflect the survival seen with targeted therapies and immunotherapy, nor do they incorporate…
Novel Therapies, Inflammatory Markers for Survival Estimates for Lung Cancer with Bone Mets
